Advertisement

Ophthalmology

The first ophthalmologic biosimilar did not launch in the U.S. until July 2022, and some prescribers are still cautious about their uses, according to Cardinal Health's 2023 "Biosimilars Report," which surveyed over 350 providers in four physician specialties. 

Advertisement

From  a new OCLI Vision acquisition to renewed medical partnerships, here are 16 ophthalmology updates Becker's has reported on since Feb. 1. 

Optical instrument designer and manufacturer Precision Optics has entered into a production and technology licensing agreement with a global medical company. 

Advertisement